The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
基本信息
- 批准号:9922099
- 负责人:
- 金额:$ 288.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-15 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AddressAdultAdvisory CommitteesAgeAged, 80 and overAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAlzheimer&aposs disease therapyAsian AmericansAutopsyBasic ScienceBiological MarkersBloodBrain DiseasesBrain PathologyCaliforniaClinicalClinical ResearchClinical SciencesClustered Regularly Interspaced Short Palindromic RepeatsCognitiveCommunitiesComplexComputer softwareConsentCountyDataData AnalysesData SetDementiaDevelopmentDiagnosisDimensionsDiseaseDown SyndromeEducationEnsureEpidemicEthicsEthnic groupEtiologyFacultyGeneticGoalsImageImpaired cognitionIndividualInfrastructureInternationalKnowledgeLeadershipLongevityMissionModernizationMolecularNatureOlder PopulationOrangesOutcomeParticipantPathogenesisPathologicPathway interactionsPatientsPlayPopulations at RiskPredispositionProductivityProtocols documentationRecording of previous eventsRegistriesResearchResearch MethodologyResearch PersonnelResourcesRoleScholarshipScienceScientistSocietiesStainsSumTechnologyTrainingTranslational ResearchUniversitiesVisionWorkaging populationbiomarker developmentbrain tissuecell bankcohortdata managementdata resourceeducation researcheffective therapyin vivoinduced pluripotent stem cellinnovationinsightinterdisciplinary approachinterdisciplinary collaborationmeetingsmild cognitive impairmentmultidisciplinarynamed groupneuroimagingneuroimaging markerneuropathologynext generationnovelnovel diagnosticsopen sourceparticipant retentionpreventprodromal Alzheimer&aposs diseaserecruitresiliencestem cell biologysuccess
项目摘要
UCI ADRC Overall
Project Summary/Abstract
The central theme of the University of California, Irvine Alzheimer's Disease Research Center (UCI ADRC) is
to identify, quantify, and validate factors that influence the risk of Alzheimer's disease (AD) across the lifespan.
Given its diverse and multifactorial nature, it is critical to understand the etiology and progression of this
insidious brain disorder at multiple dimensions, including clinically and neuropathologically, and to employ
novel scientific approaches so that we can advance knowledge and better diagnose, prevent and cure the
disease. The UCI ADRC has a strong history of integrating basic, clinical, and translational science to gain
insights into AD pathogenesis and to help meet some of the goals of the National Alzheimer's Project Act.
First, our Center has a distinguished record of studying the disease in diverse patient cohorts: Uniform Data
Set (UDS) Cohort, which includes cognitively normal individuals and individuals with mild cognitive impairment
(prodromal AD); adults with Down syndrome, representing the largest genetically at-risk population for AD; and
90+, which show great disparity between AD pathology and cognitive loss and are among the oldest group of
individuals to develop AD. Together, these cohorts enable interrogation of important novel questions related to
age, susceptibility and resilience, using innovative outcomes ranging from in vivo biomarker characterization to
modern pathological outcomes such as post-mortem imaging and microglial staining. Second, the UCI ADRC
has a history of innovation that has helped advance the field; the development of the nation's first induced
pluripotent stem cell bank for AD as part of the ADRC network and our recently established Consent-to-
Contact recruitment registry are recent examples of this innovation. Third, our Center continues to evolve.
Given the expertise, productivity, and resources devoted the study of special populations at UCI, we have
initiated two Special Populations Cores, one focused on Down syndrome and one focused on the oldest old
(90+). These Cores will interact with the other cores of the ADRC to produce novel data and resources
available to ADRC investigators, including through our newly established Biomarker Core. Finally, we have
established a new Research and Education Component in this proposal, which harnesses the long-standing
passionate commitment to training the next generation of clinicians and scientists at UCI. In sum, the UCI
ADRC brings energetic and innovative multi-dimensional and multidisciplinary approaches toward addressing
the national epidemic of AD.
UCI ADRC总体
项目摘要/摘要
加州大学欧文分校阿尔茨海默病研究中心(UCI ADRC)的中心主题是
识别、量化和验证影响一生中阿尔茨海默病(AD)风险的因素。
鉴于其多样性和多因素的性质,了解其病因和进展至关重要。
包括临床和神经病理在内的多个维度的潜伏性脑功能障碍,并使用
新的科学方法,使我们能够提高知识,更好地诊断、预防和治疗
疾病。UCI ADRC在整合基础、临床和转化科学以获得
深入了解阿尔茨海默病的发病机制,并帮助实现国家阿尔茨海默氏症项目法的一些目标。
首先,我们中心在研究不同患者队列中的疾病方面有着卓越的记录:统一的数据
SET(UDS)队列,包括认知正常个体和轻度认知障碍个体
(先兆阿尔茨海默病);患有唐氏综合症的成年人,这是阿尔茨海默病的最大遗传风险人群;以及
90岁以上,在AD病理和认知障碍之间显示出巨大的差异,是年龄最大的
个体发展成AD。总而言之,这些队列使审问与以下相关的重要新问题成为可能
年龄、易感性和韧性,使用创新成果,从体内生物标记物表征到
现代病理结果,如尸检成像和小胶质细胞染色。第二,UCI ADRC
有帮助推进该领域的创新的历史;国家第一个诱导的
作为ADRC网络的一部分的AD多能干细胞库和我们最近建立的同意-
联系招聘登记处就是这种创新的最新例子。第三,我们的中心继续发展。
鉴于UCI致力于特殊人群研究的专业知识、生产力和资源,我们有
启动了两个特殊人群核心,一个专注于唐氏综合症,另一个专注于最年长的老年人
(90+)。这些核心将与ADRC的其他核心交互,以产生新的数据和资源
通过我们新成立的Biomarker Core向ADRC调查人员提供。最后,我们有
在这项提案中建立了一个新的研究和教育部分,利用了长期存在的
充满激情地致力于在UCI培训下一代临床医生和科学家。总而言之,UCI
ADRC带来了充满活力和创新的多维度和多学科方法来解决
阿尔茨海默病的全国性流行。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FRANK M LAFERLA其他文献
FRANK M LAFERLA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FRANK M LAFERLA', 18)}}的其他基金
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
解读白细胞介素 18 在阿尔茨海默氏病中作为 tau 蛋白病理驱动因素的作用
- 批准号:
10463741 - 财政年份:2021
- 资助金额:
$ 288.37万 - 项目类别:
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
解读白细胞介素 18 在阿尔茨海默氏病中作为 tau 蛋白病理驱动因素的作用
- 批准号:
10636861 - 财政年份:2021
- 资助金额:
$ 288.37万 - 项目类别:
Deciphering the role of interleukin-18 as a driver of tau pathology in Alzheimer's disease
解读白细胞介素 18 在阿尔茨海默氏病中作为 tau 蛋白病理驱动因素的作用
- 批准号:
10280235 - 财政年份:2021
- 资助金额:
$ 288.37万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10582616 - 财政年份:2020
- 资助金额:
$ 288.37万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10774385 - 财政年份:2020
- 资助金额:
$ 288.37万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10747262 - 财政年份:2020
- 资助金额:
$ 288.37万 - 项目类别:
The Alzheimer's Disease Research Center at the University of California, Irvine
加州大学欧文分校阿尔茨海默病研究中心
- 批准号:
10188380 - 财政年份:2020
- 资助金额:
$ 288.37万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 288.37万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 288.37万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 288.37万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 288.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 288.37万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 288.37万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 288.37万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 288.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 288.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 288.37万 - 项目类别:
Grant-in-Aid for Scientific Research (C)